Cardiovascular Research
Cardiogen and Vesugen are associated with different areas of cardiovascular and vascular research. They remain separate compounds and should be reviewed individually.
Explore Dragon Pharma peptide bioregulators organized around different tissue and organ research areas. Compare products including Cartalax, Cardiogen, Livagen, Vesugen and other specialized bioregulators by strength, format and available documentation.
Product Information
This category brings together Dragon Pharma peptide bioregulators associated with different tissue and organ research areas. Unlike broader peptide groups organized around a common hormone pathway, these products are typically distinguished by the biological system or tissue with which they are associated.
Cardiogen and Vesugen are associated with different areas of cardiovascular and vascular research. They remain separate compounds and should be reviewed individually.
Products such as Bronchogen, Livagen, Ovagen and Prostamax are associated with research focused on particular organs or tissue systems.
Cartalax is associated with cartilage and connective-tissue research, while other bioregulators in the range are linked with different tissue-specific research areas.
Bioregulators are a specialized group, and their evidence base can differ from more extensively studied therapeutic peptides and medicines.
The product names can make this group difficult to navigate for someone encountering peptide bioregulators for the first time. A simple way to compare them is by their main tissue or research association.
Bioregulators are better compared by active peptide and research area than by product strength alone. Two products supplied at the same milligram amount can be associated with completely different tissues and should not be considered alternatives simply because their vial sizes are similar.
The individual product page provides the product strength, container information and available supporting documentation for each Dragon Pharma bioregulator.
The research background for peptide bioregulators is not the same as that of established prescription medicines. Evidence varies between compounds, and organ or tissue associations should not be interpreted as proof that a product can prevent, treat or reverse disease in that organ.
When comparing products, consider the specific compound, the type of evidence available and whether findings come from laboratory, animal or human research.
Where laboratory testing is available, the individual product page displays the corresponding report together with details such as the test date, measured result and reported batch number.
A laboratory report provides information about the submitted sample. It does not establish the clinical effectiveness, safety or suitability of a bioregulator for a particular person.